Pharma Regulatory Summit 2019

The 2nd Annual Pharma Regulatory Summit 2019 produced by Virtue Insight is the leading platform for regulatory experts, to be updated with latest country updates and strategies to navigate the complex and ever changing regulations in the region.

The pharmaceutical industry is a highly regulated industry. The regulatory requirements are permanently growing to ensure supply of high pharmaceutical quality, safety and efficacy of medicinal products. The factor time is now playing a more important role to allow expedited patient’s access to innovative medicinal products to treat their disease and improve their life. This conference will focus on the new strategies, amendments, innovations, developments in the fields of regulatory affairs, intellectual property and medical devices, which reflects new strategies in the field of regulatory affairs. Regulatory Affairs additionally have certain significance inside the Healthcare industries, such as pharmaceuticals, medical devices, biologics and practical nourishments. The regulatory capacity in healthcare services is crucial in making secured and viable social insurance items accessible around the world. People who guarantee administrative consistence and prepare submissions, and additionally those whose primary occupation activity is clinical affairs or quality affirmation are altogether viewed as regulatory experts

Virtue Insight brings you it’s 2nd Annual Pharma Regulatory Summit 2019 scheduled on 14th March in Mumbai, focusing on the clarification and interpretation to the most critical regulatory guidelines faced by the Indian Pharma companies.

It gives us immense pleasure in welcoming you to the 2nd Annual Pharma Regulatory Summit 2019


KEY THEMES DISCUSSED:-

• Visions for the future – Pharma Regulatory 2020
• Current state of regulatory compliance in Pharma industry
• Global regulatory challenges and current hot topics in the regulatory world
• Conducting an innovative and commercialization hub in India
• Conception and Digitalisation – The impact and where do we go next?
• Directing the regulatory environment in India
• Expedited approval timelines and process - Overview and case studies
• Discussing on the recent harmonization regulatory efforts in Asia for the pharma products
• Companies & Gov – How should they work together? 
• Different regulatory obligation for enrolling drug products for the regulatory process for obtaining marketing authorizations for drugs in ASEAN region
• Compendial standards usage for quality medicine regulation
• Post-Marketing surveillance & safety in India
• Post marketing monitoring and evaluation of the safety and effectiveness of all medicines
• Impacts and Opportunities for IP strategies in regulatory affairs – Globally & Digitally
• Future conceptualization for IP strategies and its regulatory significance
• An essential management aspect on GMPs
• Keeping tracks on GMP production and quality control
• Leading quality manufacturer in regulated industries including food, drugs and medical devices
• India’s current regulatory scenario and structure – what’s changed and what else to expect
• Be part of a major networking opportunity

WHO SHOULD ATTEND:-

This conference is specifically designed for pharma, biotech, CRO’s, Government and Regulators, Hospitals/Trial Sites, Technology & Solution Providers and med device professionals responsible for:

• Regulatory Affairs
• Regulatory Writing/Medical Writing/Publishing/Information/Submissions
• Document and eRecords Management
• Business Operations/Processing
• Labelling
• Clinical Trials Management/Data
• Clinical Data
• Outsourcing/Clinical Outsourcing/Vendor Management
• Product Development
• Quality Assurance/Quality Control

WHY SHOULD YOU ATTEND?

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.